Tracy C. Vargo-Gogola, Ph.D.
Affiliations: | 2002 | Vanderbilt University, Nashville, TN |
Area:
Cell Biology, OncologyGoogle:
"Tracy Vargo-Gogola"Parents
Sign in to add mentorLynn M. Matrisian | grad student | 2002 | Vanderbilt | |
(The mechanisms by which matrix metalloproteinase-7 promotes mammary tumorigenesis.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bray K, Gillette M, Young J, et al. (2013) Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration. Breast Cancer Research : Bcr. 15: R91 |
Gillette M, Bray K, Blumenthaler A, et al. (2013) P190B RhoGAP overexpression in the developing mammary epithelium induces TGFβ-dependent fibroblast activation. Plos One. 8: e65105 |
Hwang M, Peddibhotla S, McHenry P, et al. (2012) P190B RhoGAP Regulates Chromosome Segregation in Cancer Cells. Cancers. 4: 475-89 |
Gillette M, McHenry P, Blumenthaler A, et al. (2012) Abstract 32: P190B RhoGAP overexpression drives mammary epithelial cell proliferation by altering stromal-epithelial interactions in the developing mammary gland Cancer Research. 72: 32-32 |
Bray K, Brakebusch C, Vargo-Gogola T. (2011) The Rho GTPase Cdc42 is required for primary mammary epithelial cell morphogenesis in vitro. Small Gtpases. 2: 247-258 |
Heckman-Stoddard BM, Vargo-Gogola T, Herrick MP, et al. (2011) P190A RhoGAP is required for mammary gland development. Developmental Biology. 360: 1-10 |
McHenry PR, Sears JC, Herrick MP, et al. (2010) P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis. Breast Cancer Research : Bcr. 12: R73 |
Lynch CC, Vargo-Gogola T, Matrisian LM, et al. (2010) Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA. Journal of Oncology. 2010: 530745 |
Vargo-Gogola T. (2010) Putting the brakes on breast cancer: therapeutic opportunities to bring cancer stem cells and the tumor microenvironment to a screeching halt. Current Drug Targets. 11: 1041-1042 |
McHenry PR, Vargo-Gogola T. (2010) Pleiotropic Functions of Rho GTPase Signaling: a Trojan Horse or Achilles’ Heel for Breast Cancer Treatment? Current Drug Targets. 11: 1043-1058 |